These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19106544)

  • 1. [Effective combination chemotherapy with gemcitabine hydrochloride, S-1 and nedaplatin for recurrent pancreatic cancer--a case report].
    Tokairin Y; Iida M; Yamazaki S
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2123-5. PubMed ID: 19106544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of complete response of gemcitabine (GEM) monotherapy-refractive liver metastatic pancreatic cancer treated with GEM+S-1 combined chemotherapy].
    Hatata T; Takaya S; Taniguchi K; Naka T; Kondo A; Ikeguchi M
    Gan To Kagaku Ryoho; 2011 Jan; 38(1):109-12. PubMed ID: 21368469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of advanced pancreatic cancer responding to combination chemotherapy with the individual maximum repeatable dose of gemcitabine and oral S-1].
    Fujimoto C; Maruyama Y; Niina Y; Fujimori N; Sumii T; Funakoshi A
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):1013-6. PubMed ID: 18633236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of recurrent pancreatic cancer with lung metastasis responding to S-1 combined gemcitabine chemotherapy].
    Fukada I; Ikeda H; Yamaguchi K; Okabe M; Tsuruta A; Morimoto Y; Kawamoto K; Sano K; Paku T; Imai S; Yoshida Y; Ito T; Ogasahara K
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1733-6. PubMed ID: 19838037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [S-1+gemcitabine (GEM) therapy effective in a case of pancreatic body cancer with multiple liver metastasis].
    Fukui H; Kou C; Matsumoto T; Matsumoto M
    Gan To Kagaku Ryoho; 2010 Sep; 37(9):1775-8. PubMed ID: 20841945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of advanced pancreatic cancer successfully treated by combined chemotherapy of S-1 and gemcitabine].
    Kawasaki H; Kukita K; Mizushima Y; Hirata K
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1239-42. PubMed ID: 18633272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of salvage chemotherapy with gemcitabine hydrochloride and nedaplatin for gemcitabine-refractory pancreatic cancer].
    Matsuda M; Watanabe G; Hashimoto M
    Gan To Kagaku Ryoho; 2008 Jan; 35(1):137-9. PubMed ID: 18195544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [S-1+gemcitabine (GEM) therapy was effective in a case of unresectable pancreatic head carcinoma].
    Takada J; Okuda K; Kenno S; Shimada S; Oba G; Shimokuni T; Aoki T; Hamada H
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2120-2. PubMed ID: 19106543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of S-1/gemcitabine combination therapy for advanced pancreatic cancer].
    Hara T; Nagata M; Yamashita Y; Fujimoto K; Muraki Y; Yasuda Y; Kurahashi T
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1233-7. PubMed ID: 18633271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of metastatic pancreatic cancer after combination chemotherapy with uracil-tegafur and gemcitabine].
    Sugimoto K; Okada K; Nakahira S; Okamura S; Miki H; Nakata K; Suzuki R; Yoshimura M; Uji K; Yoshida A; Tamura S
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):321-3. PubMed ID: 19223756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of liver metastasis of pancreatic acinar cell carcinoma treated with S-1 and intra-arterial CDDP combination therapy].
    Fujii M; Sato H; Ogasawara T; Ando T; Tsujii S; Nagahori J; Komatsu Y; Matsuoka A
    Gan To Kagaku Ryoho; 2010 Oct; 37(10):1987-90. PubMed ID: 20948270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of advanced pancreatic cancer responding well to S-1/gemcitabine combination therapy after gemcitabine therapy].
    Kuji M; Yamamoto Y; Tani C; Kenno S; Kobayashi T
    Gan To Kagaku Ryoho; 2011 May; 38(5):853-5. PubMed ID: 21566453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcitabine and S-1 combination chemotherapy versus gemcitabine alone for locally advanced and metastatic pancreatic cancer: a meta-analysis of randomized controlled trials in Asia.
    Li Y; Sun J; Jiang Z; Zhang L; Liu G
    J Chemother; 2015 Aug; 27(4):227-34. PubMed ID: 25790948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The progress of chemotherapy for advanced pancreatic cancer].
    Ioka T; Katayama K; Ashida R; Takahashi H; Teshima T; Sakon M
    Nihon Shokakibyo Gakkai Zasshi; 2015 Dec; 112(12):2119-26. PubMed ID: 26638783
    [No Abstract]   [Full Text] [Related]  

  • 15. [A case of stage IV b pancreatic head cancer that was resected because of a good response to chemotherapy].
    Ohara T; Fujino Y; Goto H; Yamashita H; Oyama M; Katsura M; Sugiyama H; Ueda Y; Hasegawa H; Yasuda T; Kakinoki K; Oshikiri T; Sendo H; Sugimoto T; Tominaga M
    Gan To Kagaku Ryoho; 2015 May; 42(5):633-5. PubMed ID: 25981662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of Complete Response(CR)to combination therapy of S-1 and Gemcitabine(GEM)for unresectable pancreatic cancer].
    Miyagawa K; Yata Y; Yamaoka N; Sagara Y
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):1145-7. PubMed ID: 20567125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of gemcitabine-refractory pancreatic cancer responsive to second-line chemotherapy using S-1.
    Morizane C
    Jpn J Clin Oncol; 2007 Dec; 37(12):973. PubMed ID: 18211987
    [No Abstract]   [Full Text] [Related]  

  • 18. [A Case of Gemcitabine Refractory Lung Metastasis after Distal Pancreatectomy for Pancreatic Cancer, Effectively Treated with S -1 as Second Line Chemotherapy].
    Omori K; Wakabayashi K; Suematsu Y; Suda H; Hiratsuka M; Takahashi M; Saito H; Ishibashi Y; Morita A; Ito Y
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1582-4. PubMed ID: 26805103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of gemcitabine-based chemo-radiation therapy for unresectable pancreatic cancer with liver metastases].
    Yamashita S; Sakon M; Hiura Y; Nakano K; Higaki N; Murakami M; Hayashida H; Kan K; Ichihara T
    Gan To Kagaku Ryoho; 2007 Nov; 34(12):2010-2. PubMed ID: 18219882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical benefit of full-dose gemcitabine for advanced pancreatic cancer refractory to S-1+gemcitabine].
    Hachisuka H; Takahashi M; Kushima A; Nakamoto T; Takahashi K; Iwamura Y; Wakata M; Nagano K; Nakajima T; Nunomura M; Araki K
    Gan To Kagaku Ryoho; 2013 May; 40(5):639-42. PubMed ID: 23863590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.